TrialScientific reports2023

In a secondary analysis from a randomised, double-blind placebo-controlled trial Dexmedetomidine blocks cholinergic dysregulation in delirium pathogenesis in patients with major surgery.

Yanite Jacob et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.